[Skip to Content]
[Skip to Content Landing]
October 1986

Neodymium-YAG Vitreous Surgery for Phakic and Pseudophakic Malignant Glaucoma

Author Affiliations

From the University Glaucoma Consultants, Department of Ophthalmology, University of Texas Health Science Center at Dallas.

Arch Ophthalmol. 1986;104(10):1464-1466. doi:10.1001/archopht.1986.01050220058026

• Ciliary block (malignant glaucoma) developed in a phakic eye and a pseudophakic eye with a posterior chamber intraocular lens and an intact posterior capsule. In both cases, neodymium-YAG laser treatment (2 to 3 mJ) to the anterior vitreous relieved the blockage, and the anterior chamber returned to normal depth. When technically possible, the neodymium-YAG laser may be used to treat phakic and pseudophakic malignant glaucoma before resorting to surgical vitrectomy.

Simmons RJ,  Thomas JV: Malignant glaucoma , in Ritch R, Shields MB (eds): The Secondary Glaucomas . St Louis, CV Mosby Co, 1982, pp 331-344.
Epstein DL, Steinert RF, Puliafito CA:  Neodymium-YAG laser therapy to the anterior hyaloid in aphakic malignant (cilio-vitreal block) glaucoma . Am J Ophthalmol 1984;98:137-143.
Shrader CE, Belcher CD, Thomas JV, et al:  Pupillary and iridovitreal block in pseudophakic eyes . Ophthalmology 1984;91:831-837.Article
Shaffer RN:  The role of vitreous detachment in aphakic and malignant glaucoma . Trans Am Acad Ophthalmol Otolaryngol 1954;58:217-231.
Epstein DL, Hashimoto JM, Anderson PF, et al:  Experimental perfusions through the anterior and vitreous chambers with possible relationships to malignant glaucoma . Am J Ophthalmol 1979;88:1078-1086.
Quigley HA:  Malignant glaucoma and fluid flow rate . Am J Ophthalmol 1980;89:879-880.